|Articles|April 27, 2021
Red Blood Cell Contaminants: Upstream Mitigation for Downstream Success
Author(s)BioIVT
When isolating peripheral blood mononuclear cells (PBMCs) from whole blood, red blood cell (RBC) contamination can have a significant impact on your downstream results. In this white paper, learn the sources of RBC contamination, the downstream impact of RBC contamination and mitigation strategies that will improve your results.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
2
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
3
Implementing Automation and Flexible Design for Allogeneic Manufacturing
4
Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths
5
